Jayne Toledano Miranda's most recent trade in Journey Medical Corp was a trade of 20,000 Common Stock, $0.0001 par value done . Disclosure was reported to the exchange on Aug. 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Journey Medical Corp | Miranda Jayne Toledano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2025 | 20,000 | 108,618 | - | 0 | Common Stock, $0.0001 par value | |
| Entera Bio | Miranda Jayne Toledano | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Entera Bio | Miranda Jayne Toledano | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 136,842 | 371,715 (3%) | 1% | 0 | Ordinary Shares, par value NIS 0.0000769 per share | |
| Entera Bio | Miranda Jayne Toledano | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 43,860 | 415,575 (3%) | 0% | 0 | Ordinary Shares, par value NIS 0.0000769 per share | |
| Journey Medical Corp | Miranda Jayne Toledano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2025 | 7,173 | 88,618 | - | 0 | Common Stock, $0.0001 par value | |
| Entera Bio | Miranda Jayne Toledano | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2024 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Entera Bio | Miranda Jayne Toledano | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2024 | 124,121 | 234,873 (2%) | 1% | 0 | Ordinary Shares, par value NIS 0.0000769 per share | |
| Journey Medical Corp | Miranda Jayne Toledano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2024 | 9,728 | 81,445 | - | 0 | Common Stock, $0.0001 par value | |
| Entera Bio | Miranda Toledano Jayne | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Dec 2023 | 23,952 | 23,952 | - | - | Warrants (right to buy) | |
| Entera Bio | Jayne Toledano Miranda | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.71 per share. | 22 Dec 2023 | 23,952 | 110,752 (0%) | 0% | 0.7 | 17,006 | Ordinary Shares, par value NIS 0.0000769 per share |
| Nexgel Inc | Miranda Jayne Toledano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Journey Medical Corp | Miranda Jayne Toledano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 27,472 | 71,717 | - | 0 | Common Stock, par value $0.0001 per share | |
| Entera Bio | Miranda Jayne Toledano | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 04 Apr 2023 | 30,000 | 86,800 (0%) | 0% | 1.0 | 30,300 | Ordinary Shares, par value NIS 0.0000769 per share |
| Entera Bio | Miranda Jayne Toledano | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.53 per share. | 11 Nov 2022 | 50,000 | 56,800 (0%) | 0% | 0.5 | 26,585 | Ordinary Shares, par value NIS 0.0000769 per share |
| Entera Bio | Miranda Jayne Toledano | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Sep 2022 | 600,000 | 600,000 | - | - | Stock Option (right to buy) | |
| Entera Bio | Miranda Jayne Toledano | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Sep 2022 | 500,000 | 500,000 | - | - | Stock Option (right to buy) | |
| Journey Medical Corp | Miranda Jayne Toledano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2022 | 14,245 | 44,245 | - | 0 | Common Stock, par value $0.0001 per share | |
| Journey Medical Corp | Miranda Jayne Toledano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 30,000 | 30,000 | - | 0 | COMMON STOCK | |
| Entera Bio | Miranda Jayne Toledano | Director | Purchase of securities on an exchange or from another person at price $ 2.79 per share. | 14 Jan 2022 | 6,800 | 6,800 (0%) | 0% | 2.8 | 18,971 | Ordinary Shares, par value NIS 0.0000769 per share |
| Entera Bio | Miranda Jayne Toledano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 107,557 | 107,557 | - | - | Stock Option (right to buy) | |
| Entera Bio | Miranda Jayne Toledano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 35,852 | 35,852 | - | - | Stock Option (right to buy) |